Asta, through its third-party managing agency at Lloyd’s, has received in-principle approval of an innovative syndicate-in-a-box (SIAB) to provide a “breakthrough” insurance product that will insure exposures previously deemed ‘unsuitable’ for insurance, and help accelerate the development of new therapeutic drugs.